Por favor, inténtelo con una nueva búsqueda
ZyVersa Therapeutics, Inc. es una empresa biofarmacéutica en fase clínica que desarrolla y comercializa productos para el tratamiento de enfermedades renales e inflamatorias. La empresa se dedica al desarrollo de VAR 200, un mediador del eflujo de colesterol, que está en fase 2a de ensayo clínico para el tratamiento de múltiples indicaciones renales, como la glomeruloesclerosis segmentaria focal, el síndrome de alport y la nefropatía diabética; y de IC 100, un anticuerpo monoclonal inhibidor del inflamasoma ASC que está en fase preclínica para el tratamiento de multitud de enfermedades inflamatorias. ZyVersa Therapeutics, Inc. tiene su sede en Weston, Florida.
Nombre | Edad | Desde | Título |
---|---|---|---|
Sharon G. Adler | - | - | Member of Scientific Advisory Board |
Stephen C. Glover | 63 | 2022 | Co-Founder, Chairman, CEO & President |
Pablo A. Guzman | 73 | 2023 | Chief Medical Officer, Senior VP of Medical Affairs & Chairman of Renal Scientific Advisory Board |
Min-Chul Park | 41 | 2022 | Independent Director |
Robert W. Keane | - | - | Member of Scientific Advisory Board |
Douglas H. Farrar | 58 | - | Member of Scientific Advisory Board |
Alan C. Herman | 75 | - | Member of Scientific Advisory Board |
William F. Bennett | 74 | - | Member of Scientific Advisory Board |
Robert G. Finizio | 52 | 2022 | Independent Director |
Miguel S. Barbosa | 65 | - | Member of Scientific Advisory Board |
Marlene Haffner | 82 | - | Member of Scientific Advisory Board |
Fernando C. Fervenza | - | - | Member of Renal Scientific Advisory Board |
W. Dalton Dietrich | 70 | - | Member of Scientific Advisory Board |
Daniel G. Baker | - | - | Member of Scientific Advisory Board |
James R. Sapirstein | 62 | 2023 | Independent Director |
Gregory G. Freitag | 61 | 2023 | Independent Director |
Nicholas A. LaBella | 67 | 2022 | Member of Scientific Advisory Board |
Juan Pablo de Rivero Vaccari | - | - | Member of Scientific Advisory Board |
Alessia Fornoni | - | - | Member of Scientific Advisory Board |
Helen Bramlett | - | - | Member of Scientific Advisory Board |
Daniel C. Cattran | - | - | Member of Renal Scientific Advisory Board |
Richard J. Glassock | - | 2023 | Member of Renal Scientific Advisory Board |
Douglas T. Golenbock | - | 2023 | Member of Scientific Advisory Board |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores